Drug development for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction-associated steatohepatitis (MASH), has been surprisingly challenging 1
Semaglutide administered subcutaneously lowers HbA1c more than any other long-acting medication
Kristin Louden: Well, today there are several GLP-1 medications available
Botulinum toxin, a potent inhibitor of neuromuscular transmission, has been reported to improve emptying and symptoms for several months in DGp and idiopathic gastroparesis in several open label studies [128]
"If information is changing in as little as a day, how can we expect everyday Americans, doctors, or even HR and benefits leaders, to make sense of it all
Product positioning belongs in documentation, COA review, identity testing, lot traceability, and RUO labeling